2021
DOI: 10.1016/j.jbc.2021.100697
|View full text |Cite
|
Sign up to set email alerts
|

Loss of Down syndrome critical region-1 leads to cholesterol metabolic dysfunction that exaggerates hypercholesterolemia in ApoE-null background

Abstract: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 38 publications
0
1
0
Order By: Relevance
“…Extraction and fractionation of nuclear and cytoplasmic proteins were performed as described previously. 49 The antibodies used for the western blotting were as follows: FOXO1, Ser256 phosphorylated FOXO1, β-actin, lamin A, and β-tubulin. HRP-conjugated secondary antibodies used were anti-rabbit IgG and anti-mouse IgG.…”
Section: Methodsmentioning
confidence: 99%
“…Extraction and fractionation of nuclear and cytoplasmic proteins were performed as described previously. 49 The antibodies used for the western blotting were as follows: FOXO1, Ser256 phosphorylated FOXO1, β-actin, lamin A, and β-tubulin. HRP-conjugated secondary antibodies used were anti-rabbit IgG and anti-mouse IgG.…”
Section: Methodsmentioning
confidence: 99%